SkinCancer360

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy
Featured image for “Checkpoint Therapeutics Receives Approval for PD-L1 Therapy”

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy

December 16, 2024
The approval of cosibelimab-ipdl provides an option for patients with cutaneous squamous cell carcinoma December 13, 2024 (Sacramento, California) The…
Featured image for “AIM at Melanoma Announces the Launch of AIM at Skin Cancer”

AIM at Melanoma Announces the Launch of AIM at Skin Cancer

January 22, 2024
New Website Dedicated to Providing Individuals with Vital Knowledge and Tools to Protect Their Skin and Lead Healthy Lives January…
[wpb_childpages]

Recent Posts

Featured image for “Checkpoint Therapeutics Receives Approval for PD-L1 Therapy”
Dec. 16, 2024

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy

Featured image for “Active Military Service Veterans are at Risk for Skin Cancers”
Dec. 03, 2024

Active Military Service Veterans are at Risk for Skin Cancers

Featured image for “Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure”
Nov. 05, 2024

Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure

Featured image for “Social Awareness and Support Needed for Spouses of Patients Recently Diagnosed With Cancer”
Sep. 24, 2024

Social Awareness and Support Needed for Spouses of Patients Recently Diagnosed With Cancer

Featured image for “A Brief History of Mohs Surgery”
Sep. 16, 2024

A Brief History of Mohs Surgery

Post Categories